We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

23 hedge funds and large institutions have $30.4M invested in Global Cord Blood Corporation in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2323 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

3% less capital invested

Capital invested by funds: $31.3M → $30.4M (-$830K)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
23
Holders Change
Holders Change %
0%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
2
Increased
Reduced
Closed
2
Calls
$161K
Puts
Net Calls
+$161K
Net Calls Change
+$74K

CO Hedge Fund Activity: Q1 2023 in Review

23 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2023, worth a combined $30.4M — down 2.7% from $31.3M a quarter earlier.

Fund positioning in CO was balanced in Q1 2023: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Clark Financial Services Group, opening a new position worth an estimated $37K. The largest seller was Man Group, exiting entirely with an estimated $5.38M sold.

  • 23 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $30.4M of Global Cord Blood Corporation stock for Q1 2023, down 2.7% quarter-over-quarter.
  • 2 funds opened new Global Cord Blood Corporation positions in Q1 2023 and 2 closed out, a net change of 0 holders.
  • The largest Global Cord Blood Corporation buyer in Q1 2023 was Clark Financial Services Group, an estimated $37K added.
  • The largest Global Cord Blood Corporation seller in Q1 2023 was Man Group, an estimated $5.38M sold.

Based on aggregated 13F filings for Q1 2023.